Stress, Inflammation and Neuroimaging in Major Depressive Disorder as Compared to Premenstrual Dysphoric Disorder

Recruiting Observational Study
MDD PMDD
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Female
Study type
Observational
Participants needed
75 (estimated)
Sponsor
University Hospital Tuebingen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Premenstrual dysphoric disorder (PMDD) is a sex-specific depressive disorder where depressive symptom severity drastically changes in relation to menstrual cycle phase. It is characterized by late luteal phase symptoms of affective lability, irritability, depressed mood, and anxiety. A lot remains unclear and further studies are needed in order to improve the understanding of PMDD and to different…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women, * age between 18 and 40 years (no menopausal women), * regular menstrual cycles (25-31 days), * normal body mass index (18-35 kg/m2), * German language fluency Exclusion Criteria: * any neurological or mental disease (only for healthy participants) * hormonal, metabol…
Contacts

Elise Bücklein, M.Sc.

+497071-2982627

elise.buecklein@uni-tuebingen.de

CONTACT